📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs (2018)

First Author: Holmes E

Attributed to: Renewal of the Network of Hubs for Trials Methodology Research. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1231

PubMed Identifier: 30204252

Publication URI: http://europepmc.org/abstract/MED/30204252

Type: Journal Article/Review

Parent Publication: Clinical Pharmacology & Therapeutics

Issue: 3

ISSN: 0009-9236